sales, general, and administrative expenses

(redirected from Selling, General and Administrative Expense)

Sales, General, and Administrative Expenses

Overhead costs to a company. Sales, general, and administrative expenses are usually recurring; they include things like rent, salaries, and money spent on office supplies. They do not generally include one-time costs. They form one of the single largest expenses a company can incur in its operations. These expenses are included in one category on financial statements and are subtracted from revenue when calculating operating income.

sales, general, and administrative expenses (SG&A)

Corporate overhead costs for a period including expenses such as advertising, salaries, and rent. SG&A is found on a corporate income statement as a deduction from revenues in calculating operating income.
References in periodicals archive ?
The divestiture of PEG will also enable Magnetek to reduce selling, general and administrative expense (SG&A) and interest expense substantially, resulting in positive operating profit and cash flow.
E[acute accent]Selling, General and Administrative - Selling, general and administrative expense increased to $9.
While revenues for both quarters rose dramatically, and gross profit was likewise up, selling, general and administrative expenses increased 233.
Selling, general and administrative expenses and overall operating expense increased $0.
Selling, general and administrative expenses are now forecast to be in the range of $255 million to $265 million, as a result of increasing legal expenses primarily related to ongoing patent-infringement litigation.
The loss from operations was $886,734 for the three months ended March 31, 2006, which was primarily due to selling, general and administrative expenses amounting to $886,521 for the same time period.
The broad-based program is primarily focused on the company's research and development operations and selling, general and administrative expenses across all divisions.
Included in the fourth quarter 2005 results are $315,000 of stock-based compensation charges, which included the impact of accelerated option vesting the Company granted several former executives in lieu of cash severance; adjustments related to the Company's May 2005 IT system conversion; and increased selling, general and administrative expenses, including Sarbanes-Oxley compliance and professional consulting fees and accelerated depreciation of the Company's IT system.
The Company expects to realize reduced selling, general and administrative expenses going forward as a result of these measures.
After the Company received notification in February 2005 that the USPS would not renew the CBU contract, the Company's Board of Directors reviewed the Company's strategic alternatives, with the assistance of outside advisors, and adopted a restructuring plan, summarized in the Annual Report, to reduce annual selling, general and administrative expenses significantly, primarily though personnel reductions in Jamestown, New York and the relocation of the Company's headquarters to its owned facilities in Grapevine, Texas, by the end of 2005.
The higher loss was primarily a result of the company's increased research and development activities, including the sequencing of its C1 organism in conjunction with Agencourt Bioscience, and increased selling, general and administrative expenses to meet increased financial reporting requirements of being a public company as well as expenses associated with hiring additional personnel to support new marketing initiatives for the company's Enzyme Business.